Methylprednisolone Addition in IVF Treatment of Infertile Couples
Information source: Universitair Ziekenhuis Brussel
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: In Vitro Fertilization
Intervention: In vitro fertilization treatment for infertility (Other)
Phase: Phase 4
Status: Recruiting
Sponsored by: Universitair Ziekenhuis Brussel Official(s) and/or principal investigator(s): Basil Tarlatzis, Professor, Study Chair, Affiliation: BioGenesis
Overall contact: Evangelos Papanikolaou, MD, Phone: 0030 2310 424284, Email: drvagpapanikolaou@yahoo.gr
Summary
Hypothesis to be tested is whether follicular addition of Methylprednisolone can efficiently
control late follicular progesterone rise during IVF treatment
Clinical Details
Official title: Methylprednisolone vs. Placebo to Control Late Follicular Progesterone Elevation in GnRH-Antagonist IVF Cycles
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
Primary outcome: Progesterone rise above 1.5ng.ml on the day of HCG
Secondary outcome: Clinical pregnancy rate
Detailed description:
The aim is to investigate any potential advantages of adding cortisone supplementation from
the follicular phase onwards with regard to premature luteinization, oocyte quality, embryo
quality and pregnancy outcome.
Eligibility
Minimum age: 21 Years.
Maximum age: 36 Years.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- less than 36, more than 10 antral follicles, FSH<12
Exclusion Criteria:
- endometriosis stage III&IV,
Locations and Contacts
Evangelos Papanikolaou, MD, Phone: 0030 2310 424284, Email: drvagpapanikolaou@yahoo.gr
Biogenesis, Thessaloniki, Pylaia 55536, Greece; Recruiting Evangelos Papanikolaou, MD,PhD, Phone: 0030 2310 989160, Email: drvagpapanikolaou@yahoo.gr
Additional Information
web page of investigator centre
Related publications: Bider D, Menashe Y, Goldenberg M, Dulitzky M, Lifshitz A, Dor J. Dexamethasone as an adjuvant therapy for anovulatory, normoandrogenic patients during ovulation induction with exogenous gonadotropins. J Assist Reprod Genet. 1996 Sep;13(8):613-6.
Starting date: January 2009
Last updated: October 13, 2010
|